Skip to main content
Good evening, these are the top coronavirus headlines tonight:

Top headlines:

An increasing number of health agencies have changed how they're reporting data on the coronavirus. A look at the current numbers in Canada for reported cases, deaths from COVID-19 and for hospitalizations can be found here.

COVID-19 updates from Canada and the world

Looking for more top headlines? Subscribe to our Morning Update and Evening Update newsletters to get caught up on our latest stories.

Pandemic recovery

  • China’s manufacturing and services activities shrank further in November to seven-month lows, official data showed, stung by the country’s strict COVID-19 restrictions and rising infections that analysts said will hurt the economy well into 2023.
  • The U.S. Food and Drug Administration has pulled its emergency authorization of a COVID-19 antibody co-developed by Eli Lilly & Co. and Vancouver’s AbCellera Biologics Inc. after determining the drug is not expected to neutralize the two latest subvariants of the virus.
  • Pediatricians are urging parents to get their kids routine vaccines for preventable diseases like measles following a drop in vaccinations during the pandemic.
  • The number of people in Europe with undiagnosed HIV has risen as testing rates fell during the pandemic, according to a joint report from the World Health Organization and the European Centre for Disease Prevention and Control.

Want in-depth analysis on what governments are doing with your tax dollars? Subscribe to our Tax & Spend newsletter.

Globe opinion

Samir Sinha: Canada’s health care systems must do more to protect at-risk people from the flu

Want to hear more from our columnists? Subscribe to the Opinion newsletter, and get it in your inbox, Monday to Saturday.

Information centre

Thank you for subscribing to our Coronavirus Update Newsletter. As the pandemic eases, we plan to wind this down and eventually cease sending, but have many other newsletters to keep you informed, including Globe Climate, Carrick on Money and Breaking News.

Reach out to us: